Safety and tolerability of intravenous immunoglobulin

Author： Martin T.D.  

Publisher： Elsevier

ISSN： 0013-4694

Source： Electroencephalography and Clinical Neurophysiology, Vol.103, Iss.1, 1997-07, pp. : 52-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulin ‐ How to use it

By  

PRACTICAL NEUROLOGY, Vol. 1, Iss. 2, 2001-12 ,pp. : 93-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sertindole: safety and tolerability profile

By Kasper S  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 27-32

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intravenous immunoglobulin and plasma exchange in demyelinating neuropathies

By Feasby T.E.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 72-72

Elsevier

Access to resources Recommend Favorite

The mechanism of action of intravenous immunoglobulin (IVIG) in demyelinating neuropathies

By Pollard J.D.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 72-73

Elsevier

Access to resources Recommend Favorite

Intravenous immunoglobulin shows potential as treatment for pain syndrome

By  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 173-175

Future Medicine

Access to resources Recommend Favorite